- Home
- AMS vs NCNA Comparison
AMS vs NCNA Comparison
Compare AMS & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMS
- NCNA
- Stock Information
- Founded
- AMS 1980
- NCNA 1997
- Country
- AMS United States
- NCNA United Kingdom
- Employees
- AMS N/A
- NCNA N/A
- Industry
- AMS Medical Specialities
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- AMS Health Care
- NCNA Health Care
- Exchange
- AMS Nasdaq
- NCNA Nasdaq
- Market Cap
- AMS 17.2M
- NCNA 15.4M
- IPO Year
- AMS N/A
- NCNA 2017
- Fundamental
- Price
- AMS $2.48
- NCNA $4.47
- Analyst Decision
- AMS
- NCNA Buy
- Analyst Count
- AMS 0
- NCNA 2
- Target Price
- AMS N/A
- NCNA $25.00
- AVG Volume (30 Days)
- AMS 4.2K
- NCNA 187.0M
- Earning Date
- AMS 08-13-2025
- NCNA 08-18-2025
- Dividend Yield
- AMS N/A
- NCNA N/A
- EPS Growth
- AMS 151.01
- NCNA N/A
- EPS
- AMS 0.21
- NCNA N/A
- Revenue
- AMS $29,236,000.00
- NCNA N/A
- Revenue This Year
- AMS $9.95
- NCNA N/A
- Revenue Next Year
- AMS N/A
- NCNA N/A
- P/E Ratio
- AMS $11.97
- NCNA N/A
- Revenue Growth
- AMS 35.25
- NCNA N/A
- 52 Week Low
- AMS $2.27
- NCNA $0.03
- 52 Week High
- AMS $4.60
- NCNA $10.79
- Technical
- Relative Strength Index (RSI)
- AMS 46.12
- NCNA 30.91
- Support Level
- AMS $2.46
- NCNA $7.06
- Resistance Level
- AMS $2.54
- NCNA $10.00
- Average True Range (ATR)
- AMS 0.09
- NCNA 1.44
- MACD
- AMS -0.01
- NCNA 0.07
- Stochastic Oscillator
- AMS 22.22
- NCNA 3.94
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.